Systemic signs of inflammation, similar to those found in atherosclerosis, are present in patients with degenerative aortic valve stenosis. They do not seem to be linked to C. pneumoniae or H. pylori infection.

In HBeAg-negative CHB, combination PEG-IFN-alpha2a plus ADV for 48 weeks is safe and resulted in greater on-treatment efficacy than PEG-IFN-alpha2a monotherapy. No difference in sustained virological and biochemical response rates were observed between the two treatment regimens.

Solid organ transplant recipients (SOTRs) have an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection due to immunosuppression required to prevent rejection.In addition, immunosuppression may reduce the response to vaccination. 1 For this reason, SOTRs are considered at high-risk to develop severe coronavirus disease-2019 (COVID-19) with reported

Individual HBIg consumption profiles are highly variable. A low-dose (2,000 IU) on demand HBIg administration schedule is highly cost-effective and provides more than 50% savings compared with conventional high-dose monthly schedules.

No abstract